Y, S., A, U., K, T., K, M., R, I., & N, E. (2017). Short-term outcomes in patients with branch retinal vein occlusion who received intravitreal aflibercept with or without intravitreal ranibizumab. Dove Medical Press.
Cita Chicago Style (17a ed.)Y, Sakanishi, Usui-Ouchi A, Tamaki K, Mashimo K, Ito R, y Ebihara N. Short-term Outcomes in Patients with Branch Retinal Vein Occlusion Who Received Intravitreal Aflibercept with or Without Intravitreal Ranibizumab. Dove Medical Press, 2017.
Cita MLA (8a ed.)Y, Sakanishi, et al. Short-term Outcomes in Patients with Branch Retinal Vein Occlusion Who Received Intravitreal Aflibercept with or Without Intravitreal Ranibizumab. Dove Medical Press, 2017.
Precaución: Estas citas no son 100% exactas.